Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.

Journal of medical virology - 1 Oct 2002

Chan Henry Lik-Yuen, Chui Albert Ka-Keung, Lau Wan-Yee, Chan Francis Ka-Leung, Wong May-Ling, Tse Chi-Hang, Rao Araga Ramesha Nitin, Wong John, Sung Joseph Jao-Yiu

Abstract excerpt

This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients received lamivudine 100 mg daily pre- and post-transplant. Serum samples were collected before lamivudine treatment,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to Genes, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B e Antigens

Share to Lamivudine

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Recurrence

Source

Identifiers

PMID: 12210406
DOI: 10.1002/jmv.10185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.PMID 12210406Read ↗

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.Semantic proximity Read ↗

Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.Semantic proximity Read ↗

High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.Semantic proximity Read ↗

No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.Semantic proximity Read ↗

Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.Semantic proximity Read ↗

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.Semantic proximity Read ↗

Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.Semantic proximity Read ↗

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.Semantic proximity Read ↗

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis.Semantic proximity Read ↗

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.Semantic proximity Read ↗

Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Semantic proximity Read ↗

[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.